SEC Form 4 · accession 0001209191-15-078797
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jane Wasman
Officer — President, Intl and GC
Period of report
Nov 4, 2015
Accepted (ET)
Nov 6, 2015 · 7:36 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 4, 2015 | M | 8,907 | $5.85 | A | 107,004 | D | |
| Common Stock | Nov 4, 2015 | M | 7,915 | $6.00 | A | 114,919 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $5.85 | Nov 4, 2015 | M | 8,907 | D | — | Mar 17, 2016 | Common Stock | 8,907 | 16,093 | D |
| Employee Stock Option (right to buy)F2 | $6.00 | Nov 4, 2015 | M | 7,915 | D | — | Feb 15, 2016 | Common Stock | 7,915 | 3,277 | D |
Explanation of responses
- F1The shares subject to these options vested in installments and were fully vested on February 10, 2010.
- F2The shares subject to these options vested in installments and were fully vested on February 15, 2010.